As part of a May 15 reorganization, US FDA has established a new pharmaceutical inspectorate in its Office of Regulatory Affairs and apportioned the inspectorate's staff among four domestic regional divisions, one foreign division and one program division.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?